Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Al hacerlo, reproducen y amplifican sus efectos metablicos
In the United States, Medicare coverage for L-carnitine is available for patients who have been on dialysis therapy for at least 3 months, have a plasma free carnitine level less than 40 mol/L, and have erythropoietin-resistant anemiathat has not responded to standard erythropoietin dosageand for which other causes have been investigated and adequately treated. 195 Hyporesponsiveness to ESAs is not specifically defined other than having a persistent Hct less than 30% despite erythropoietin dosage that is considered clinically appropriate to treat the particular patient. The statement There is insufficient evidence to recommend use of L-carnitine in the management of anemia in patients with CKD is supported by results from 6 available RCTs of IV L-carnitine administration to ESA-treated HD patients (Table 32)
However, individual responses vary based on genetics, baseline mental health status, and dosing schedule
Stock Disponible
US$ 26.43
US$ 23.85
US$ 22.19
US$ 26.26
